European researchers advance bone implants technology

European researchers are relentless in their pursuit to develop technologies across the board. Case in point is medical technology and bone implants. Enter a team of researchers from the Germany-based Fraunhofer Institute for Manufacturing Engineering and Applied Materials Research who have developed a simulation programme calculating the internal structure and density distribution of bone material.

The production of bone implants with a structure similar to natural bone is being produced easily. The initial step in this process is the calculation of the bone's internal structure and porosity, followed by the 'baking' of the implant from metal powder. The second step is conducted in a prototyping machine.

Scientists involved in the production of bone implants look to nature for resources, taking a close look at the structure of bone and how it is constructed. While bones are light, they have the capacity to tolerate strong loads. Also, the interior of bone is sponge-like but firm and compact in some areas.

With this in mind, the Fraunhofer team rose to the challenge of the lightweight construction industry which asked 'How can this be replicated?' The researchers successfully developed a simulation programme that shows how bone structure must be constructed in order to meet the specified requirements.

This latest development gives engineers the means to produce complex components with the help of rapid prototyping technology. The process focuses on coating a surface with wafer-thin layers of special metal powder. A laser beam sinters (heats without melting) ores or powdery metals into a coherent mass in the areas that must be firm.

"It's like baking a cake," explains Andreas Burblies, a representative for the Fraunhofer Numerical Simulation of Products, Processes Alliance. "The end product is an open-pored element. Any remaining loose powder is then removed. Each point possesses exactly the right density and thus also a certain stability," he adds.

Engineers can now make lightweight components that are tailor-made for each application. The upshot is that these components will be able to withstand heavy loads. The research team has also given the engineers the means to change the internal structure of the parts once they are produced through precision drilling.

"We can manufacture and adapt the parts exactly as required," Mr Burblies says. Experts have said that the production of individual implants with an internal structure that is similar to a patient's bone is not difficult. Biomaterials-based metal powders, like steel alloys and titanium, give engineers an edge because reconstruction of other bone elements is made easy. This innovative technique will draw in several industries, including bone implants production, and aircraft and automobile manufacturers.

For more information, please visit:
http://www.ifam.fraunhofer.de

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Johnson & Johnson Announces Submission to Worl…

Johnson & Johnson (NYSE: JNJ) (the Company) announced that Janssen-Cilag International N.V. has submitted for Emergency Use Listing (EUL) to the World Health Organization...

Anticancer drug may improve outcome for severe COV…

Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China ...

Pfizer and BioNTech commence global clinical trial…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in a global Phase 2/3 study to further evaluate the saf...

GSK and Vir Biotechnology expand coronavirus colla…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) have signed a binding agreement to expand their existing collaboration to include the resear...

Sanofi to provide manufacturing support to Johnson…

Sanofi has entered into an agreement with Janssen Pharmaceutical NV and Janssen Pharmaceuticals, Inc., two of the Janssen Pharmaceutical Companies of Johnson & Johnson, u...

One dose of COVID-19 vaccine provokes strong immun…

Although clinical trial data are encouraging, real-world evidence with regard to the COVID-19 vaccine remains scarce. In particular, response to the vaccine among those p...

Could a nasal spray prevent coronavirus transmissi…

A nasal antiviral created by researchers at Columbia University Vagelos College of Physicians and Surgeons blocked transmission of SARS-CoV-2 in ferrets, suggesting the n...

European Commission purchases additional 150 milli…

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Commission purchased an...

Sanofi and GSK initiate new Phase 2 study of their…

Sanofi and GlaxoSmithKline (GSK) announced the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most appropriate antigen dosage for Ph...

CureVac initiates rolling submission with European…

CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today annou...

Neandertal gene variants both increase and decreas…

Last year, researchers at Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany showed that a major genetic risk ...

Pfizer and BioNTech publish data from in vitro stu…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication in Nature Medicine of data from in vitro studies that demonstrate that sera from in...